Literature DB >> 33303344

Compulsory and voluntary drug treatment models in China: A need for improved evidence-based policy and practice to reduce the loaded burden of substance use disorders.

Jie Yang1, Melita J Giummarra2.   

Abstract

In China, the majority of people who use drugs (PWUD) identified by authorities are admitted to compulsory isolated detoxification centers in which their treatment is administered by administrative and judicial systems that restrict their freedom. China's compulsory isolated detoxification centers have been criticized as an abuse of human rights. The two other primary models of drug treatment in China include community-based treatment and medically-oriented voluntary treatment. This article presents an overview of the three primary treatment models for PWUD currently practiced in China. The existing compulsory and voluntary treatment models predominantly operate separately from each other, and lack evidence-based guidelines. A drug treatment system that embraces social support, psychosocial interventions and well-qualified health-based workforce is currently lacking. We propose that China needs to employ a localized model that is composed of well-facilitated and evidence-based treatment methods for both compulsory and voluntary treatment for PWUD to reduce the burden of illicit drug use. The implementation of these models of care, however, need to be tailored to the country's historical background, large population of PWUD and cultural settings in order to succeed. Urgent changes in drug treatment policies and practices are needed by the Chinese governments at different levels, organizations and front-line practitioners if we are to see a reduction in the incidence and impact of harms related to substance use in China.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  Addiction; China; Drug treatment models; Evidence-based methods; Substance use disorders

Mesh:

Substances:

Year:  2020        PMID: 33303344     DOI: 10.1016/j.drugpo.2020.103063

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  6 in total

1.  Understanding Vietnam's drug policy for amphetamine-type stimulants misuse.

Authors:  Mai Thi Ngoc Tran; Michael P Dunne; Giang Minh Le; Hoe Dinh Han; Trang Thu Nguyen; Hai Thanh Luong; Quang Hung Luong; Ha Nguyen Pham; Philip Baker
Journal:  Harm Reduct J       Date:  2022-05-13

2.  Evaluating the Risk of Suicide and Violence in Severe Mental Illness: A Feasibility Study of Two Risk Assessment Tools (OxMIS and OxMIV) in General Psychiatric Settings.

Authors:  Gabrielle Beaudry; Manuel Canal-Rivero; Jianjun Ou; Jaskiran Matharu; Seena Fazel; Rongqin Yu
Journal:  Front Psychiatry       Date:  2022-06-30       Impact factor: 5.435

3.  No Exit: China's State Surveillance over People Who Use Drugs.

Authors:  Mu Lin; Nina Sun; Joseph J Amon
Journal:  Health Hum Rights       Date:  2022-06

4.  How Anti-Substance Abuse Campaigns Influence Substance Abusers' Psychological Health in Chinese Communities: The Mediating Role of Perceived Stigma.

Authors:  Yonghui Zeng; Li Han; Yu Cheng; Cindy Xinshan Jia
Journal:  Int J Environ Res Public Health       Date:  2022-05-30       Impact factor: 4.614

5.  A Multi-Site Cross-Sectional Study of Anxiety Symptoms and the Associated Factors Among Chinese Drug Users Undergoing Compulsory Detoxification Treatment.

Authors:  Xiaoshi Yang; Carrie Kovarik; Yuke Wang; Shenshui Yu
Journal:  Front Public Health       Date:  2021-03-11

6.  Treatments, Perceived Stigma, and Employment Outcomes among Substance Abusers in China.

Authors:  Li Han; Cindy Xinshan Jia
Journal:  Healthcare (Basel)       Date:  2022-01-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.